PL3113782T3 - Układy podawania leku i sposoby leczenia raka pęcherza moczowego gemcytabiną - Google Patents
Układy podawania leku i sposoby leczenia raka pęcherza moczowego gemcytabinąInfo
- Publication number
- PL3113782T3 PL3113782T3 PL15711373.9T PL15711373T PL3113782T3 PL 3113782 T3 PL3113782 T3 PL 3113782T3 PL 15711373 T PL15711373 T PL 15711373T PL 3113782 T3 PL3113782 T3 PL 3113782T3
- Authority
- PL
- Poland
- Prior art keywords
- gemcitabine
- treatment
- methods
- drug delivery
- delivery systems
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Anesthesiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Nanotechnology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461949215P | 2014-03-06 | 2014-03-06 | |
| PCT/US2015/019262 WO2015134911A1 (en) | 2014-03-06 | 2015-03-06 | Drug delivery systems and methods for treatment of bladder cancer with gemcitabine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3113782T3 true PL3113782T3 (pl) | 2023-01-23 |
Family
ID=52697553
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15711373.9T PL3113782T3 (pl) | 2014-03-06 | 2015-03-06 | Układy podawania leku i sposoby leczenia raka pęcherza moczowego gemcytabiną |
| PL22196596.5T PL4124339T3 (pl) | 2014-03-06 | 2015-03-06 | Układy dostarczania leków i sposoby leczenia nowotworu pęcherza moczowego gemcytabiną |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL22196596.5T PL4124339T3 (pl) | 2014-03-06 | 2015-03-06 | Układy dostarczania leków i sposoby leczenia nowotworu pęcherza moczowego gemcytabiną |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US20150250717A1 (enExample) |
| EP (2) | EP4124339B1 (enExample) |
| JP (5) | JP6901858B2 (enExample) |
| KR (1) | KR102338079B1 (enExample) |
| CN (2) | CN119950539A (enExample) |
| AU (4) | AU2015226901B2 (enExample) |
| BR (1) | BR112016020381A8 (enExample) |
| CA (1) | CA2939979C (enExample) |
| DK (2) | DK3113782T3 (enExample) |
| ES (2) | ES3051417T3 (enExample) |
| FI (1) | FI4124339T3 (enExample) |
| HR (2) | HRP20251264T1 (enExample) |
| HU (1) | HUE060704T2 (enExample) |
| IL (2) | IL311410B2 (enExample) |
| LT (2) | LT3113782T (enExample) |
| MX (1) | MX2016011333A (enExample) |
| PL (2) | PL3113782T3 (enExample) |
| PT (2) | PT3113782T (enExample) |
| RS (2) | RS63675B1 (enExample) |
| RU (1) | RU2694902C1 (enExample) |
| SG (2) | SG10202101978SA (enExample) |
| SI (1) | SI4124339T1 (enExample) |
| SM (2) | SMT202200449T1 (enExample) |
| WO (1) | WO2015134911A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014036556A2 (en) | 2012-08-31 | 2014-03-06 | Taris Biomedical, Inc. | Drug delivery systems and methods for treatment of prostate |
| IL299897B2 (en) | 2013-08-19 | 2024-02-01 | Taris Biomedical Llc | Devices and methods for administering multiple units of drug |
| PT3113782T (pt) | 2014-03-06 | 2023-01-05 | Taris Biomedical Llc | Sistemas e métodos de administração de fármaco para tratamento do cancro da bexiga com gemcitabina |
| SG11201809838VA (en) * | 2016-05-06 | 2018-12-28 | Taris Biomedical Llc | Method of treating lower tract urothelial cancer |
| US10857173B2 (en) * | 2017-07-25 | 2020-12-08 | Taris Biomedical Llc | Methods of treating tumor metastasis |
| KR102892737B1 (ko) * | 2017-11-08 | 2025-11-28 | 타리스 바이오메디컬 엘엘씨 | 젬시타빈을 사용한 방광암의 치료 및 유지 요법의 방법 |
| AU2019315957A1 (en) | 2018-08-01 | 2021-02-18 | Taris Biomedical Llc | Methods of treating overactive bladder using trospium |
| JP7660066B2 (ja) * | 2019-10-03 | 2025-04-10 | 生化学工業株式会社 | 膀胱の粘膜下組織への医薬品有効成分の経粘膜的送達システム |
| RU2713443C2 (ru) * | 2019-11-01 | 2020-02-05 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр радиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ радиологии" Минздрава России) | Способ комбинированного лечения мышечно-инвазивного рака мочевого пузыря т3-т4 n0-+m0 |
| JP2023512652A (ja) * | 2020-01-27 | 2023-03-28 | アイソラ セラピューティクス，インコーポレイテッド | 管腔内局所薬剤送達のための組織内投与 |
| CN112169066B (zh) * | 2020-10-29 | 2023-05-12 | 安徽省立医院(中国科学技术大学附属第一医院) | 具有控制器的连续缓释给药留置管 |
| CN113616666A (zh) * | 2021-08-24 | 2021-11-09 | 傅广波 | 膀胱黏膜下注射吉西他滨在治疗膀胱癌中的应用 |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| US4111203A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system with means for improving delivery kinetics of system |
| US6171298B1 (en) | 1996-05-03 | 2001-01-09 | Situs Corporation | Intravesical infuser |
| CA2432438C (en) | 2001-01-09 | 2011-04-26 | Microchips, Inc. | Flexible microchip devices for ophthalmic and other applications |
| US7534241B2 (en) * | 2002-09-23 | 2009-05-19 | Microchips, Inc. | Micro-reservoir osmotic release systems and microtube array device |
| US20040260272A1 (en) | 2002-10-22 | 2004-12-23 | Friedman Craig D. | Method and system for intravesicular delivery of therapeutic agents |
| CA2520610A1 (en) * | 2003-03-31 | 2004-10-21 | Alza Corporation | Osmotic pump with means for dissipating internal pressure |
| US8361490B2 (en) * | 2004-09-16 | 2013-01-29 | Theracoat Ltd. | Biocompatible drug delivery apparatus and methods |
| EP1933810B1 (en) | 2005-08-11 | 2012-10-10 | Massachusetts Institute of Technology | Intravesical drug delivery device and method |
| CA2649877A1 (en) * | 2006-04-24 | 2007-12-21 | Gloucester Pharmaceuticals | Gemcitabine combination therapy |
| EP1913962A1 (en) | 2006-10-22 | 2008-04-23 | Ophir Perelson | Expandable medical device for the treatment and prevention of cardiovascular diseases |
| EA201070703A1 (ru) | 2007-12-11 | 2010-12-30 | Массачусетс Инститьют Оф Текнолоджи | Имплантируемое устройство для доставки лекарства и способы лечения мочевого пузыря и других полостей тела или трубчатых органов |
| JP5538359B2 (ja) | 2008-04-04 | 2014-07-02 | リペラ ファーマシューティカルズ， インコーポレイテッド | リポソームボツリヌス毒素を使用する膀胱機能障害の治療 |
| EP2313122B1 (en) | 2008-07-17 | 2019-03-06 | Micell Technologies, Inc. | Drug delivery medical device |
| EA201170297A1 (ru) | 2008-08-09 | 2011-08-30 | Массачусетс Инститьют Оф Текнолоджи | Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей |
| CA2765630C (en) | 2009-06-26 | 2016-07-05 | Taris Biomedical, Inc. | Solid drug tablets for implantable drug delivery devices |
| US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| US8721621B2 (en) | 2009-09-10 | 2014-05-13 | Taris Biomedical, Inc. | Systems and methods for deploying devices to genitourinary sites |
| AU2010339821B2 (en) | 2009-12-17 | 2015-02-19 | Taris Biomedical Llc | Implantable device with intravesical tolerability and methods of treatment |
| EP2525777B1 (en) * | 2010-01-20 | 2019-05-29 | UroGen Pharma Ltd. | Material and method for treating internal cavities |
| US20110218488A1 (en) | 2010-03-05 | 2011-09-08 | Taris Biomedical, Inc. | Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites |
| JP2013527232A (ja) | 2010-06-02 | 2013-06-27 | アブラクシス バイオサイエンス， エルエルシー | 膀胱がんの処置方法 |
| US9492266B2 (en) | 2010-08-05 | 2016-11-15 | Taris Biomedical Llc | Ureteral stent drug delivery device, kit, and method |
| WO2012048104A1 (en) | 2010-10-06 | 2012-04-12 | Taris Biomedical, Inc. | Implantable drug delivery device with bladden retention feature |
| WO2012048114A1 (en) | 2010-10-06 | 2012-04-12 | Taris Biomedical, Inc. | Time-selective bioresorbable or collapsible drug delivery systems and methods |
| EA035494B1 (ru) | 2010-10-27 | 2020-06-25 | Прометик Фарма Смт Лимитед | Способ и применение композиции для ингибирования миграции клеток опухоли и образования метастазов |
| US8979797B2 (en) | 2010-12-16 | 2015-03-17 | Ams Research Corporation | High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics |
| JP2014503554A (ja) | 2011-01-10 | 2014-02-13 | タリス バイオメディカル，インコーポレイテッド | 膀胱痛及び刺激性排尿の持続的治療の使用のためのリドカインレジメン |
| ES2637388T3 (es) * | 2011-02-04 | 2017-10-13 | Taris Biomedical, Inc. | Dispositivo implantable para la liberación controlada de un fármaco de baja solubilidad |
| US20150005595A1 (en) | 2011-12-30 | 2015-01-01 | Kibur Medical, Inc. | Implantable devices and methods for evaluation of active agents |
| KR20190134832A (ko) | 2012-03-29 | 2019-12-04 | 알토 바이오사이언스 코포레이션 | 종양 형성 치료방법 |
| US10058688B2 (en) | 2012-05-09 | 2018-08-28 | Massachusetts Institute Of Technology | Medicament, method, and drug delivery device for treatment of ovarian cancer |
| WO2014036556A2 (en) * | 2012-08-31 | 2014-03-06 | Taris Biomedical, Inc. | Drug delivery systems and methods for treatment of prostate |
| PL2890384T3 (pl) | 2012-08-31 | 2022-02-14 | Taris Biomedical Llc | Układy podawania leku i sposoby leczenia raka pęcherza obejmujące oksaliplatynę |
| EP2897616A1 (en) | 2012-09-18 | 2015-07-29 | TARIS Biomedical LLC | Drug delivery systems and methods for treatment of bladder voiding dysfunction!and other lower urinary tract disorders by using trospium |
| JP2016508842A (ja) | 2013-03-05 | 2016-03-24 | タリス バイオメディカル エルエルシー | 装置の開口部を通じて制御された薬物放出のための薬物送達装置及び方法 |
| PL2968880T3 (pl) | 2013-03-15 | 2025-06-23 | Taris Biomedical Llc | Urządzenia do dostarczania leku ze składnikiem przepuszczalnym dla leku |
| MX391755B (es) | 2013-03-15 | 2025-03-21 | Taris Biomedical Llc | Dispositivos de administración de medicamentos y métodos para administración de medicamentos. |
| JP6431528B2 (ja) | 2013-04-10 | 2018-11-28 | マサチューセッツ インスチテュート オブ テクノロジーＭａｓｓａｃｈｕｓｅｔｔｓ Ｉｎｓｔｉｔｕｔｅ Ｏｆ Ｔｅｃｈｎｏｌｏｇｙ | 癌治療のための薬物局所送達装置及び方法 |
| IL299897B2 (en) * | 2013-08-19 | 2024-02-01 | Taris Biomedical Llc | Devices and methods for administering multiple units of drug |
| BR112016010103A8 (pt) * | 2013-11-05 | 2018-01-30 | Taris Biomedical Llc | métodos, kits e dispositivos de suprimento de fármaco osmótico. |
| PT3113782T (pt) | 2014-03-06 | 2023-01-05 | Taris Biomedical Llc | Sistemas e métodos de administração de fármaco para tratamento do cancro da bexiga com gemcitabina |
| RU2591946C2 (ru) | 2014-06-24 | 2016-07-20 | Владимир Эдуардович Анников | Способ изготовления гелеобразного водосодержащего взрывчатого состава |
| KR20230142816A (ko) | 2014-06-26 | 2023-10-11 | 타리스 바이오메디컬 엘엘씨 | 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법 |
| EP4744688A2 (en) | 2015-04-23 | 2026-05-20 | Janssen Biotech Inc | DRUG DELIVERY DEVICES WITH A DRUG-PERMEABLE COMPONENT AND METHODS |
| SG11201809838VA (en) | 2016-05-06 | 2018-12-28 | Taris Biomedical Llc | Method of treating lower tract urothelial cancer |
| US10857173B2 (en) | 2017-07-25 | 2020-12-08 | Taris Biomedical Llc | Methods of treating tumor metastasis |
| KR102892737B1 (ko) | 2017-11-08 | 2025-11-28 | 타리스 바이오메디컬 엘엘씨 | 젬시타빈을 사용한 방광암의 치료 및 유지 요법의 방법 |
| AU2019315957A1 (en) | 2018-08-01 | 2021-02-18 | Taris Biomedical Llc | Methods of treating overactive bladder using trospium |
-
2015
- 2015-03-06 PT PT157113739T patent/PT3113782T/pt unknown
- 2015-03-06 CN CN202510128139.2A patent/CN119950539A/zh active Pending
- 2015-03-06 SM SM20220449T patent/SMT202200449T1/it unknown
- 2015-03-06 RS RS20220937A patent/RS63675B1/sr unknown
- 2015-03-06 JP JP2016555554A patent/JP6901858B2/ja active Active
- 2015-03-06 SM SM20250385T patent/SMT202500385T1/it unknown
- 2015-03-06 EP EP22196596.5A patent/EP4124339B1/en active Active
- 2015-03-06 CA CA2939979A patent/CA2939979C/en active Active
- 2015-03-06 RS RS20251017A patent/RS67337B1/sr unknown
- 2015-03-06 ES ES22196596T patent/ES3051417T3/es active Active
- 2015-03-06 LT LTEPPCT/US2015/019262T patent/LT3113782T/lt unknown
- 2015-03-06 EP EP15711373.9A patent/EP3113782B1/en active Active
- 2015-03-06 US US14/641,009 patent/US20150250717A1/en not_active Abandoned
- 2015-03-06 FI FIEP22196596.5T patent/FI4124339T3/fi active
- 2015-03-06 CN CN201580011259.9A patent/CN106102751A/zh active Pending
- 2015-03-06 LT LTEP22196596.5T patent/LT4124339T/lt unknown
- 2015-03-06 PT PT221965965T patent/PT4124339T/pt unknown
- 2015-03-06 SI SI201532080T patent/SI4124339T1/sl unknown
- 2015-03-06 KR KR1020167027303A patent/KR102338079B1/ko active Active
- 2015-03-06 ES ES15711373T patent/ES2930435T3/es active Active
- 2015-03-06 DK DK15711373.9T patent/DK3113782T3/da active
- 2015-03-06 SG SG10202101978SA patent/SG10202101978SA/en unknown
- 2015-03-06 AU AU2015226901A patent/AU2015226901B2/en active Active
- 2015-03-06 IL IL311410A patent/IL311410B2/en unknown
- 2015-03-06 SG SG11201607342QA patent/SG11201607342QA/en unknown
- 2015-03-06 DK DK22196596.5T patent/DK4124339T3/da active
- 2015-03-06 HU HUE15711373A patent/HUE060704T2/hu unknown
- 2015-03-06 MX MX2016011333A patent/MX2016011333A/es unknown
- 2015-03-06 PL PL15711373.9T patent/PL3113782T3/pl unknown
- 2015-03-06 RU RU2016136103A patent/RU2694902C1/ru active
- 2015-03-06 BR BR112016020381A patent/BR112016020381A8/pt not_active Application Discontinuation
- 2015-03-06 HR HRP20251264TT patent/HRP20251264T1/hr unknown
- 2015-03-06 PL PL22196596.5T patent/PL4124339T3/pl unknown
- 2015-03-06 IL IL247347A patent/IL247347B2/en unknown
- 2015-03-06 HR HRP20221252TT patent/HRP20221252T1/hr unknown
- 2015-03-06 WO PCT/US2015/019262 patent/WO2015134911A1/en not_active Ceased
-
2019
- 2019-10-04 JP JP2019184023A patent/JP7061595B2/ja active Active
-
2020
- 2020-08-12 AU AU2020217383A patent/AU2020217383B2/en active Active
-
2021
- 2021-11-11 JP JP2021183995A patent/JP7383681B2/ja active Active
- 2021-12-23 US US17/561,540 patent/US20220117886A1/en not_active Abandoned
-
2022
- 2022-07-07 US US17/811,296 patent/US12582599B2/en active Active
- 2022-08-08 AU AU2022215156A patent/AU2022215156B2/en active Active
-
2023
- 2023-11-08 JP JP2023190543A patent/JP7802743B2/ja active Active
-
2024
- 2024-11-08 AU AU2024259822A patent/AU2024259822A1/en active Pending
-
2026
- 2026-01-07 JP JP2026001498A patent/JP2026062972A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273679A (en) | Medical pad systems and methods | |
| IL247347A0 (en) | Systems and methods for administering drugs to treat bladder cancer using gemcitabine | |
| IL248757B2 (en) | Controllable drug delivery system and method of use | |
| IL259735B (en) | Systems and methods for controlled drug delivery pumps | |
| IL255372A0 (en) | Therapeutic and diagnostic methods for cancer | |
| PT3294770T (pt) | Métodos terapêuticos e diagnósticos para o cancro | |
| EP3151913A4 (en) | Systems and methods of treating a neurological disorder in a patient | |
| SG11201608483PA (en) | Drug delivery systems and related methods of use | |
| EP3180044A4 (en) | Implantable therapeutic delivery system and methods thereof | |
| SG11201701035SA (en) | Cancer diagnosis and therapy | |
| GB2537770B (en) | Methods and processes for application of drug delivery polymeric coatings | |
| IL253157A0 (en) | Systems and methods for improving the transfer of molecules that encourage bone growth for bone restoration | |
| IL250814A0 (en) | A drug release device and a container to store it | |
| SG11201605745VA (en) | Targeting clptm1l for treatment and prevention of cancer | |
| GB201511159D0 (en) | Controlled cell delivery vehicle and treatment of tumours | |
| GB201419540D0 (en) | Delivery of drugs | |
| EP3157524A4 (en) | Methods of treating cancer and preventing cancer drug resistance | |
| EP3169399A4 (en) | Systems and methods for providing radiotherapy treatment | |
| IL250637A0 (en) | Targeted release of hydrophilic drugs | |
| HK1234662A1 (en) | Methods of treating and preventing cancer drug resistance | |
| GB201410695D0 (en) | Uses of oligouronates in cancer treatment |